Analysis of systemic and regional procalcitonin serum levels during liver transplantation

Transplant International

Volumn 16, Issue 7, 2003, Pages 465-470

  Fazakas, Janos ^a   Gondos, Tibor ^a   Varga, Marina ^a   Sarvary, Enikö ^a   Horovitz, Peter ^a   Perner, Ferenc ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Infection; Liver transplantation; Multiple organ failure syndrome; Organ donation; Postoperative complications; Procalcitonin

Indexed keywords

PROCALCITONIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; CALCITONIN; FEMALE; HEPATECTOMY; HEPATIC VEINS; HUMANS; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PORTAL VEIN; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN PRECURSORS; REPERFUSION; TISSUE AND ORGAN HARVESTING; TREATMENT OUTCOME;

EID: 0042026847     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2003.tb00334.x     Document Type: Article

References (13)

1. Brunkhorst FM, Heinz U, Forycki ZF (1998) Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24:888-892
2. Cooper D, Sharples L, Cornelissen J, Wallwork J, Alexander G, Trull A (2001) Comparison between procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation. Transplant Proc 33:1808-1810
3. Hammer C, Reichenspurner R, Meiser B, Reichart B (1998) Cytoimmunology in monitoring: the Munich experience. Transplant Proc 30:873-874
4. Kretzschmar M, Kruger A, Schirrmeister W (20016) Procalcitonin following elective partial liver resection origin from the liver? Acta Anaesthesiol Scand 45:1162-1167
5. Kunz D, Pross M, König W, Lippert H, Manger T (1998) Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation. Transplant Proc 30:2398-2399
6. Kuse ER, Jaeger K (2001) Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease. Transpl Int 14:55
7. Kuse ER, Langefeld I, Jaeger K, Külpmann WR (2000) Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med 28:555-559
8. Meisner M (2000) Procalcitonin (PCT). A new innovative infection parameter. Biochemical and clinical aspects. Thieme, Stuttgart New York
9. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680-684
10. Meisner M, Müller V, Khakpour Z, Tögel E, Redl H (2001) Induction of procalcitonin in an anhepatic baboon endotoxin shock model (abstract). Shock 15[Suppl 1]:38
11. Oberhoffer M, Vogelsang H, Jager L, Reinhart K (1999) Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content. J Crit Care 14:29-33
12. Silomon M, Bach F, Ecker D, Graeter T, Grundmann U, Larsen R (1999) Procalcitonin after extracorporeal circulation. Synthesis in the hepatosplanchnic region (in German). Anaesthetist 48:395-398
13. Wagner FD, Jonitz B, Potapov EV, Qedra N, Wegscheider K, Abraham K, Ivanitskaia EA, Loebe M, Hetzer R (2001) Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation. Circulation 104 [Suppl 1]:I192-I196